Member Info for Timster

Nothing to do with Avacta then

It's a double bluff, don't fall for it......

It's not though is it...

Amazing, it's also extremely consistent across rats and dogs. As per the comments in the interview where the data was described as remarkably consistent by Fiona McLaughlin

https://youtu.be/PWrjyiR-r6o

Part of the answer may be in the post okehurst just posted the PK data presented in the poster for rats and dogs will be similar for the human trial (possibly)

What news are you expecting in July?

it says the same on the avacta website. No mention that it doesn't work.
https://avacta.com/therapeutics/precision/

The market will love this Monday... The old sneaky news release inflection point job ad

And of course we mustn't forget BEGO on the bid

I did answer PK data and proof ava6k works.

So you've held long term but have no idea of up coming milestones? Interesting

Ceesor, do you fall in to the category I posted in the other thread, 100% in a week or you're not interested?

Come back in 10 weeks

Confirmation that Ava6k works

apologies, Gadgie and gmcc

Looks like gadge is ahead of the RNS curve :)

We are delighted with the continued strong progress made by AffyXell. This joint venture with Daewoong Pharmaceutical is a key strategic collaboration allowing us to demonstrate the potential of the Affimer platform to enhance cell therapies generally, as well as providing an opportunity to address high unmet need in AffyXell's focus area of immune diseases."

Back to stupid UT today, 5% drop tomorrow

You need to install the Korean language pack Hurst bot

Could be news on that front coming then:

More broadly, one of the key areas of unmet clinical need that AffyXell can address with its next-generation mesenchymal stem cell therapies is acute pulmonary diseases such as COPD and acute respiratory distress syndrome. We, and our partners in South Korea, are very excited by the potential to develop life improving treatments for patients with these serious respiratory diseases as well as COVID-19.

I look forward to further updating the market on progress in our ground-breaking programmes with AffyXell in due course, and on progress with our COVID-19 diagnostics programmes shortly."

AACC starts Sunday, new improved affidx launch coming?

Cost of living crisis hitting hard doggy?